Suppr超能文献

红细胞输注对危重症患者的疗效:文献系统综述

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature.

作者信息

Marik Paul E, Corwin Howard L

机构信息

Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

Crit Care Med. 2008 Sep;36(9):2667-74. doi: 10.1097/CCM.0b013e3181844677.

Abstract

BACKGROUND

Red blood cell (RBC) transfusions are common in intensive care unit, trauma, and surgical patients. However, the hematocrit that should be maintained in any particular patient because the risks of further transfusion of RBC outweigh the benefits remains unclear.

OBJECTIVE

A systematic review of the literature to determine the association between red blood cell transfusion, and morbidity and mortality in high-risk hospitalized patients.

DATA SOURCES

MEDLINE, Embase, Cochrane Register of Controlled Trials, and citation review of relevant primary and review articles.

STUDY SELECTION

Cohort studies that assessed the independent effect of RBC transfusion on patient outcomes. From 571 articles screened, 45 met inclusion criteria and were included for data extraction.

DATA EXTRACTION

Forty-five studies including 272,596 were identified (the outcomes from one study were reported in four separate publications). The outcome measures were mortality, infections, multiorgan dysfunction syndrome, and acute respiratory distress syndrome. The overall risks vs. benefits of RBC transfusion on patient outcome in each study was classified as (i) risks outweigh benefits, (ii) neutral risk, and (iii) benefits outweigh risks. The odds ratio and 95% confidence interval for each outcome measure was recorded if available. The pooled odds ratios were determined using meta-analytic techniques.

DATA SYNTHESIS

Forty-five observational studies with a median of 687 patients/study (range, 63-78,974) were analyzed. In 42 of the 45 studies the risks of RBC transfusion outweighed the benefits; the risk was neutral in two studies with the benefits outweighing the risks in a subgroup of a single study (elderly patients with an acute myocardial infarction and a hematocrit <30%). Seventeen of 18 studies, demonstrated that RBC transfusions were an independent predictor of death; the pooled odds ratio (12 studies) was 1.7 (95% confidence interval, 1.4-1.9). Twenty-two studies examined the association between RBC transfusion and nosocomial infection; in all these studies blood transfusion was an independent risk factor for infection. The pooled odds ratio (nine studies) for developing an infectious complication was 1.8 (95% confidence interval, 1.5-2.2). RBC transfusions similarly increased the risk of developing multi-organ dysfunction syndrome (three studies) and acute respiratory distress syndrome (six studies). The pooled odds ratio for developing acute respiratory distress syndrome was 2.5 (95% confidence interval, 1.6-3.3).

CONCLUSIONS

Despite the inherent limitations in the analysis of cohort studies, our analysis suggests that in adult, intensive care unit, trauma, and surgical patients, RBC transfusions are associated with increased morbidity and mortality and therefore, current transfusion practices may require reevaluation. The risks and benefits of RBC transfusion should be assessed in every patient before transfusion.

摘要

背景

红细胞(RBC)输血在重症监护病房、创伤患者及外科手术患者中很常见。然而,对于特定患者应维持的血细胞比容水平仍不明确,因为进一步输注红细胞的风险是否超过益处尚无定论。

目的

系统回顾文献,以确定红细胞输血与高危住院患者的发病率和死亡率之间的关联。

数据来源

MEDLINE、Embase、Cochrane对照试验注册库以及对相关原始文献和综述文章的引用回顾。

研究选择

评估红细胞输血对患者结局独立影响的队列研究。在筛选的571篇文章中,45篇符合纳入标准并被纳入数据提取。

数据提取

共识别出45项研究,涉及272,596名患者(一项研究的结果在4篇独立出版物中报道)。结局指标包括死亡率、感染、多器官功能障碍综合征和急性呼吸窘迫综合征。每项研究中红细胞输血对患者结局的总体风险与益处被分类为:(i)风险超过益处;(ii)风险中性;(iii)益处超过风险。如有可用数据,记录每个结局指标的比值比和95%置信区间。采用荟萃分析技术确定合并比值比。

数据综合

对45项观察性研究进行分析,每项研究的患者中位数为687名(范围为63 - 78,974)。在45项研究中的42项里,红细胞输血的风险超过益处;两项研究风险中性,仅在一项研究的一个亚组(急性心肌梗死且血细胞比容<30%的老年患者)中益处超过风险。18项研究中的17项表明,红细胞输血是死亡的独立预测因素;合并比值比(12项研究)为1.7(95%置信区间为1.4 - 1.9)。22项研究探讨了红细胞输血与医院感染之间的关联;在所有这些研究中,输血都是感染的独立危险因素。发生感染并发症的合并比值比(9项研究)为1.8(95%置信区间为1.5 - 2.2)。红细胞输血同样增加了发生多器官功能障碍综合征(3项研究)和急性呼吸窘迫综合征(6项研究)的风险。发生急性呼吸窘迫综合征的合并比值比为2.5(95%置信区间为1.6 - 3.3)。

结论

尽管队列研究分析存在固有局限性,但我们的分析表明,在成年重症监护病房、创伤及外科手术患者中,红细胞输血与发病率和死亡率增加相关,因此,当前的输血实践可能需要重新评估。在对每位患者进行输血前,应评估红细胞输血的风险和益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验